$28.32
+0.08 (+0.28%)
Performance
1D
—
1W
—
1M
—
3M
-12.57%
6M
-8.32%
1Y
+62.57%
YTD
-16.34%
Open$28.20
Previous Close$28.24
Day High$28.64
Day Low$28.01
52W High$39.28
52W Low$16.82
Volume—
Avg Volume871.4K
Market Cap2.48B
P/E Ratio—
EPS$-1.30
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$34.24
Below
SMA 200
$27.52
Above
RSI (14)
49.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
+315.5% upside
Current
$28.32
$28.32
Target
$117.67
$117.67
$81.99
$117.67 avg
$158.58
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 216.55M | 133.23M | 384.15M |
| Net Income | -112,573,591 | -62,333,106 | -80,984,777 |
| Profit Margin | -52.0% | -49.4% | -21.1% |
| EBITDA | -155,065,763 | -90,631,521 | -85,173,040 |
| Free Cash Flow | — | — | -100,075,430 |
| Rev Growth | +62.5% | +62.5% | -7.8% |
| Debt/Equity | — | — | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |